SPDR Series Trust SPDR S&P Biotech ETF (XBI): Price and Financial Metrics ETF
GET POWR RATINGS... FREE!
XBI Stock Price Chart Interactive Chart >
XBI Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
Current price | $67.40 | 52-week high | $141.50 |
Prev. close | $70.14 | 52-week low | $61.78 |
Day low | $66.94 | Volume | 12,647,458 |
Day high | $69.47 | Avg. volume | 14,700,249 |
50-day MA | $81.31 | Dividend yield | 0.00001% |
200-day MA | $105.60 |
SPDR Series Trust SPDR S&P Biotech ETF (XBI) ETF Bio
The investment objective of the SPDR S&P Biotech ETF is to provide investment results that correspond generally to the total return performance of the S&P Biotechnology Select Industry Index.
XBI ETF Info
Issuer | State Street Global Advisors |
Expense Ratio | 0.35% |
Underlying Index | S&P Biotechnology Select Industry Index |
Asset Class | Equity |
Sector | Health & Biotech ETFs |
Assets Under Management (AUM) | 5.73B |
Net Asset Value (NAV) | $70.13 |
Options? | Yes |
Total Holdings | 161 |
XBI Top Holdings
Symbol | Company | % of Total |
TPTX | Turning Point Therapeutics Inc | 1.44% |
HALO | Halozyme Therapeutics Inc | 1.4% |
ALKS | ALKERMES PLC | 1.35% |
IONS | Ionis Pharmaceuticals | 1.35% |
BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | 1.31% |
IOVA | Iovance Biotherapeutics Inc | 1.28% |
VIR | Vir Biotechnology Inc | 1.22% |
DVAX | DYNAVAX TECHNO | 1.22% |
GILD | GILEAD SCI | 1.21% |
VRTX | Vertex Pharmaceuticals Inc | 1.2% |
XBI Price Returns
1-mo | -15.58% |
3-mo | -20.80% |
6-mo | N/A |
1-year | -46.44% |
3-year | -18.51% |
5-year | -2.70% |
YTD | -39.80% |
2021 | -20.45% |
2020 | 48.33% |
2019 | 32.56% |
2018 | -15.28% |
2017 | 43.77% |
XBI Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |